Allergy Diagnostics Market
Allergy Diagnostics Market - Global Industry Assessment & Forecast
#
Pages:
150
2022
Mar - 2022
VMR-1367
Segments Covered
By
Product & Service Consumables, Instruments, Immunoassay Analyzers, ELISA Analyzers, Luminometers, Services, Other Instruments
-
By
Allergen Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens
-
By
Test Type In Vivo Tests, Skin Prick Tests, Patch Tests, In Vivo Tests, Other In Vitro Tests
-
By
End User Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Other End Users
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 5327.20 Million |
 Revenue 2030:
|
USD 11841.27 Million |
 Revenue CAGR
(2023 - 2030): |
10.50% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
| Sr. No. | Offering | Report Coverage |
| 1. | Market Size | In terms of Revenue (USD Million) |
| 2. | Historic Data | 2017 to 2021 |
| 3. | Forecast Data | 2023 to 2030 |
| 4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
| 5. | Market Attractiveness Analysis | Yes |
| 6. | Segment Analysis | Maximum Segments |
| 7. | Regional Coverage | 5 Regions |
| 8. | Country Coverage | Top 22 Countries |
| 9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
| 10. | Porter’s Five Forces Analysis | Yes. |
| 11. | Value Chain Analysis | Yes |
| 12. | PEST Analysis | Yes |
| 13. | Regulatory Landscape | Yes |
| 14. | Technology Landscape | Yes |
| 15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
| 16. | Top startups to watch out for | Yes |
| 17. | Top 3 Trends to Watch | Yes |
| 18. | Top 3 Strategies Followed by Major Players | Yes |
| 19. | Top 3 Predictions by Vantage Market Research | Yes |
| 20. | Discussion Guide | Yes |
| 21. | Key Primary Respondents - VERBATIM | Yes |
| 22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
| 23. | Others/Miscellaneous | |
Vantage Market
Research | 16-Mar-2022
FAQ
Frequently Asked Question
What is the global demand for Allergy Diagnostics in terms of revenue?
-
The global Allergy Diagnostics valued at USD 5327.20 Million in 2022 and is expected to reach USD 11841.27 Million in 2030 growing at a CAGR of 10.50%.
Which are the prominent players in the market?
-
The prominent players in the market are Thermo Fisher Scientific Inc., (US), Siemens Healthineers (Germany), Danaher (US), Omega Diagnostics Group PLC (UK), bioMérieux SA (France), Romer Labs Division Holding (Austria), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (US), NEOGEN Corporation (US), Eurofins Scientific (Luxembourg), Minaris Medical America, Inc. (US), Stallergenes Greer (UK), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (US), R-Biopharm AG (Germany), AESKU.GROUP GmbH (Germany), ACON Laboratories, Inc. (US), Lincoln Diagnostics, Inc. (US), Astra Biotech GmbH (Germany), and Erba Group (UK)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 10.50% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Allergy Diagnostics include
- increasing environmental pollution globally and the increasing access to healthcare insurance
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Allergy Diagnostics in 2022.
